Currently, the PLSD reveals that overall, cancer risk for individuals carrying pathogenic variants (PVs) in MSH2 or MLH1 are similar with an approximate risk of (any) cancer being just over 70% by 70 years of age. The gene discussed is MLH1; the disease is cancer.